Cargando…

Alcohol use in opioid agonist treatment

Alcohol misuse among individuals receiving agonist treatment for an opioid use disorder is common and is associated with significant morbidity and mortality. At present, though substantial research highlights effective strategies for the screening, diagnosis and management of an alcohol or opioid us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nolan, Seonaid, Klimas, Jan, Wood, Evan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146864/ https://www.ncbi.nlm.nih.gov/pubmed/27931253 http://dx.doi.org/10.1186/s13722-016-0065-6

Ejemplares similares

Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain: A Systematic Review
por: Klimas, Jan, et al.
Publicado: (2019)

Treatment of stimulant use disorder: A systematic review of reviews
por: Ronsley, Claire, et al.
Publicado: (2020)

Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials
por: Klimas, Jan, et al.
Publicado: (2021)

Slow release oral morphine versus methadone for the treatment of opioid use disorder
por: Klimas, Jan, et al.
Publicado: (2019)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study
por: Kennedy, Mary Clare, et al.
Publicado: (2022)

Inability to access addiction treatment predicts injection initiation among street-involved youth in a Canadian setting
por: DeBeck, Kora, et al.
Publicado: (2016)

Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
por: Bardwell, Geoff, et al.
Publicado: (2023)

Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting
por: Klimas, Jan, et al.
Publicado: (2018)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

What is the benefit of inconsistent opioid agonist treatment in patients with prescription opioid use disorder?
por: Weiss, R., et al.
Publicado: (2023)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Factors associated with inability to access addiction treatment among people who inject drugs in Vancouver, Canada
por: Prangnell, Amy, et al.
Publicado: (2016)

Feasibility of alcohol screening among patients receiving opioid treatment in primary care
por: Henihan, Anne Marie, et al.
Publicado: (2016)

Prevalence of alcohol consumption among clients of opioid agonist treatment (OAT) centers in Golestan province, Iran
por: Noroozi, Alireza, et al.
Publicado: (2023)

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
por: Day, Nathaniel, et al.
Publicado: (2022)

Use of Pharmacotherapies in the Treatment of Alcohol Use Disorders and Opioid Dependence in Primary Care
por: Lee, Jinhee, et al.
Publicado: (2015)

Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
por: Redkiewicz, Patrycja, et al.
Publicado: (2021)

Trends in smoking during pregnancy stratified by the use of opioid agonist therapy and the contribution of smoking to poor outcome in neonates prenatally exposed to opioid agonist treatment
por: Kelty, Erin, et al.
Publicado: (2023)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations
por: Edinoff, Amber N., et al.
Publicado: (2021)

Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
por: Bhat, Fazle R., et al.
Publicado: (2022)

Use of Filter Paper to Measure Alcohol Biomarkers among Opioid-Dependent Patients on Agonist Maintenance Treatment: A Community-Based Study
por: Quraishi, Rizwana, et al.
Publicado: (2019)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
por: Santino, Federica, et al.
Publicado: (2023)

Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment
por: Arnet, Isabelle, et al.
Publicado: (2023)

Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon
por: Ghaddar, Ali, et al.
Publicado: (2017)

Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
por: Thakrar, Ashish P., et al.
Publicado: (2023)

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
por: Leece, Pamela, et al.
Publicado: (2019)

Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment
por: Gicquelais, Rachel E., et al.
Publicado: (2020)

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
por: Della Rocca, Filippo, et al.
Publicado: (2023)

Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method
por: Hämmig, Robert, et al.
Publicado: (2016)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study
por: von Bernuth, Kira, et al.
Publicado: (2020)

Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021
por: Rosic, Tea, et al.
Publicado: (2023)

Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
por: Bech, Anne Berit, et al.
Publicado: (2019)

Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists
por: Maslov, Leonid N, et al.
Publicado: (2016)

Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
por: Nordeck, Courtney D., et al.
Publicado: (2022)

Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
por: Li, Zoe, et al.
Publicado: (2023)

Fentanyl assisted treatment: a possible role in the opioid overdose epidemic?
por: Bardwell, Geoff, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n7ipquhteh3llf6ctq080d29iv